Positive News SentimentPositive NewsNYSE:STE STERIS (STE) Stock Price, News & Analysis $225.49 -1.16 (-0.51%) Closing price 04/1/2025 03:59 PM EasternExtended Trading$225.62 +0.14 (+0.06%) As of 04/1/2025 04:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About STERIS Stock (NYSE:STE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get STERIS alerts:Sign Up Key Stats Today's Range$222.05▼$227.6750-Day Range$216.88▼$233.0252-Week Range$197.82▼$248.24Volume803,915 shsAverage Volume529,749 shsMarket Capitalization$22.15 billionP/E Ratio47.87Dividend Yield1.01%Price Target$258.75Consensus RatingModerate Buy Company OverviewSTERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.Read More… Remove Ads STERIS Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks89th Percentile Overall ScoreSTE MarketRank™: STERIS scored higher than 89% of companies evaluated by MarketBeat, and ranked 99th out of 930 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.4 / 5Analyst RatingModerate Buy Consensus RatingSTERIS has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageSTERIS has only been the subject of 3 research reports in the past 90 days.Read more about STERIS's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth9.36% Earnings GrowthEarnings for STERIS are expected to grow by 9.36% in the coming year, from $9.08 to $9.93 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STERIS is 47.87, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.55.Price to Earnings Ratio vs. SectorThe P/E ratio of STERIS is 47.87, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.44.Price to Book Value per Share RatioSTERIS has a P/B Ratio of 3.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about STERIS's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.17% of the float of STERIS has been sold short.Short Interest Ratio / Days to CoverSTERIS has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in STERIS has recently increased by 10.58%, indicating that investor sentiment is decreasing significantly. Dividend4.2 / 5Dividend StrengthStrong Dividend YieldSTERIS pays a meaningful dividend of 1.02%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSTERIS has been increasing its dividend for 20 years.Dividend CoverageThe dividend payout ratio of STERIS is 48.41%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, STERIS will have a dividend payout ratio of 22.96% next year. This indicates that STERIS will be able to sustain or increase its dividend.Read more about STERIS's dividend. Sustainability and ESG3.8 / 5Environmental Score-2.00 Percentage of Shares Shorted1.17% of the float of STERIS has been sold short.Short Interest Ratio / Days to CoverSTERIS has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in STERIS has recently increased by 10.58%, indicating that investor sentiment is decreasing significantly. News and Social Media3.1 / 5News Sentiment1.64 News SentimentSTERIS has a news sentiment score of 1.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.77 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for STERIS this week, compared to 9 articles on an average week.MarketBeat FollowsOnly 4 people have added STERIS to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, STERIS insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.14% of the stock of STERIS is held by insiders.Percentage Held by Institutions94.69% of the stock of STERIS is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about STERIS's insider trading history. Receive STE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STERIS and its competitors with MarketBeat's FREE daily newsletter. Email Address STE Stock News HeadlinesIs STERIS Stock Underperforming the Dow?March 24, 2025 | msn.comSteris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy'March 22, 2025 | seekingalpha.comCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.April 2, 2025 | Paradigm Press (Ad)3 Reasons to Sell STE and 1 Stock to Buy InsteadMarch 20, 2025 | finance.yahoo.comWaters (WAT) Down 3.9% Since Last Earnings Report: Can It Rebound?March 15, 2025 | msn.comSteris management to meet with StephensMarch 13, 2025 | markets.businessinsider.comSteris rallies after unit enters settlment for ethylene oxide claimsMarch 4, 2025 | markets.businessinsider.com1 Healthcare Stock Primed for Growth and 2 to AvoidFebruary 18, 2025 | finance.yahoo.comSee More Headlines STE Stock Analysis - Frequently Asked Questions How have STE shares performed this year? STERIS's stock was trading at $205.56 at the start of the year. Since then, STE stock has increased by 9.7% and is now trading at $225.4870. View the best growth stocks for 2025 here. How were STERIS's earnings last quarter? STERIS plc (NYSE:STE) issued its quarterly earnings data on Wednesday, February, 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by $0.01. STERIS had a trailing twelve-month return on equity of 13.91% and a net margin of 8.66%. Read the conference call transcript. Who are STERIS's major shareholders? Top institutional shareholders of STERIS include MassMutual Private Wealth & Trust FSB. Insiders that own company stock include Michael J Tokich, John Adam Zangerle, Mohsen Sohi, Cary L Majors, Renato Tamaro and Jacqueline B Kosecoff. View institutional ownership trends. How do I buy shares of STERIS? Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of STERIS own? Based on aggregate information from My MarketBeat watchlists, some other companies that STERIS investors own include Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Visa (V), Home Depot (HD) and Advanced Micro Devices (AMD). Company Calendar Last Earnings2/05/2025Record date for 3/21 Dividend2/20/2025Ex-Dividend for 3/21 Dividend2/20/2025Dividend Payable3/21/2025Today4/02/2025Next Earnings (Estimated)5/06/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryHealth Care Equipment Current SymbolNYSE:STE CIK1624899 Webwww.steris.com Phone(440) 354-2600Fax440-639-4457Employees16,000Year Founded1987Price Target and Rating Average Stock Price Target$258.75 High Stock Price Target$265.00 Low Stock Price Target$240.00 Potential Upside/Downside+14.8%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$4.71 Trailing P/E Ratio47.87 Forward P/E Ratio24.83 P/E GrowthN/ANet Income$378.24 million Net Margins8.66% Pretax Margin14.62% Return on Equity13.91% Return on Assets8.64% Debt Debt-to-Equity Ratio0.32 Current Ratio2.13 Quick Ratio1.40 Sales & Book Value Annual Sales$5.40 billion Price / Sales4.10 Cash Flow$14.33 per share Price / Cash Flow15.73 Book Value$65.43 per share Price / Book3.45Miscellaneous Outstanding Shares98,251,000Free Float97,131,000Market Cap$22.15 billion OptionableOptionable Beta0.92 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NYSE:STE) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Tax Shock?Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STERIS plc Please log in to your account or sign up in order to add this asset to your watchlist. Share STERIS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.